Form D · Pharmaceuticals
iCeutica Inc
Philadelphia, PA · CIK 0001331270
Offering snapshot reported Mar 18, 2011 · SEC filing
- Reported sold
- $1.01M Offering amount: $1.01M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 8, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2011 | Initial | $1,010,133 | No comparison | 48 | SEC filing |
| Jul 19, 2010 | Amendment | $2,572,740 | $115,803vs Jul 1, 2010 | 89 | SEC filing |
| Jul 1, 2010 | Initial | $2,456,937 | No comparison | 84 | SEC filing |
| Dec 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 22, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-157035
Series D Preferred Stock
Source: Form D, filed Mar 18, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bill S. Bosch | Director |
| H. William Bosch | Director |
| Matt Callahan | Director, Executive |
| Matthew Callahan | Director, Executive |
| Osagie Imasogie | Director |
| Stewart Washer | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
One Crescent Drive Suite 400
Philadelphia, PA, 19112
Philadelphia, PA, 19112